Surging global prevalence of type 1 and type 2 diabetes mellitus, expanding clinical preference for intensive post-prandial glycemic control, and continuous pharmaceutical innovations in rapid-acting insulin analogues are driving rapid growth across the global Insulin Aspart Injection Market. Insulin aspart injection products—comprising standard rapid-acting insulin aspart formulations,...
